冠心病患者检测血清半胱氨酸蛋白酶抑制剂C的意义
摘要
目的探讨血清半胱氨酸蛋白酶抑制剂C与冠心病发生发展的关系。方法血清半胱氨酸蛋白酶抑制剂C测定采用透射比浊法,分别测定冠心病组和正常对照组血清半胱氨酸蛋白酶抑制剂C水平。结果冠心病组血清半胱氨酸蛋白酶抑制剂C明显高于对照组,且随着冠心病病情的加重血清半胱氨酸蛋白酶抑制剂C水平有逐步升高趋势。结论血清半胱氨酸蛋白酶抑制剂C水平与冠心病发生发展相关。
出处
《浙江实用医学》
2007年第4期236-237,共2页
Zhejiang Practical Medicine
参考文献15
-
1吴光哲,张必利,郑兴,秦永文.慢性肾脏病与冠心病相关性的临床研究[J].心血管康复医学杂志,2006,15(5):447-450. 被引量:17
-
2Anavekar N S,Mc Murray J J,Velazquez E J,et al.Relation between renal dysfunction and caediovascular outcomes after myocardial infarction.N Engl J Med.2004,351:1285
-
3Jung K,Jung M.Cystatin C:a promising marker of glomerular filtration rate to replace creatitine,Nephron,1995,70:370
-
4Newman D J,Thakkar H,Edwards R G,et al.Serum cystatin C measured by automated immunoassay:a more sensistive marker of changes in GFR than serum creatitine.Kidney Int,1995,47:312
-
5J H IX,M G Shlipak,G M Chertow,et al.Association of Cystatin C with Mortality,Cardiovascular Events,and Incident Heart Failure Among Persons With Coronary Heart Disease:Date From the Heart and Soul Study.Circulation,Janyary 16,2007;115(2):173
-
6Laterza O F,Price C P,Scott M G.Cystatin C:an improved estimater of glomerular filtration rate?Clin Chem.2002,48:699
-
7黄萍.评估肾脏功能的一种更敏感指标—胱蛋白C[J].国外医学(泌尿系统分册),2001,21(5):228-229. 被引量:13
-
8Jernberg T,Lindahl B,James S,et al.Cystatin C:a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.Circulation,2004,110:2342
-
9Pinkan T,Hilgers K F,Veelken R,et al.How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease.J Am Soc Nephrol,2004,15(3):517
-
10Fliser D,Kielstein J T,Bode-Boger S M,et al.Asymmetric dimethylarginine(ADMA):a cardiovascular risk factor in patients with renal disease.Kidney Int,2003,63(Suppl 84):S37
二级参考文献50
-
1杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量:41
-
2Foley RN, Parfrey PS, Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-S119.
-
3Witko-Sarsat V, Friedlander M, Capeillere-Blandin C,et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia.Kidney Int, 1996,49:1304-1313.
-
4Witko-Sarsat V, Friedlander M, Nguyen Khoa T,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161:2524-2532.
-
5Stein G, Busch M, Muller A, et al.Are advanced glycation end products cardiovascular risk factors in patients with CRF?Am J Kidney Dis,2003,41(3 Suppl 1):S52-S56.
-
6Craven TE, Ryu JE, Espeland MA,et al.Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.Circulation,1990,82:1230-1242.
-
7Stenvinkel P, Heimburger O, Paultre F,et al.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.Kidney Int,1999,55:1899-1911.
-
8Kaneda H, Taguchi J, Ogasawara K, et al.Increased level of advanced oxidation protein products in patients with coronary artery disease.Atherosclerosis,2002,162:221-225.
-
9Schomin M, EIcnhardt A, Rita E. The micro-inflammatory state of uremia. Blood Purif,2000,18:327-332.
-
10Santoro A, Mancini E.Cardiac effects of chronic inflammation in dialysis patients.Nephrol Dial Transplant,2002,17 Suppl 8:10-15.
共引文献66
-
1陈明红.尿毒症大中分子毒素对心血管疾病的影响[J].医学信息(医学与计算机应用),2014,0(3):458-459. 被引量:1
-
2赵万涛,王莹.尿胱氨酸蛋白抑制剂C在评估肾损害病人肾小管功能的意义[J].哈尔滨医药,2004,24(4):5-6. 被引量:1
-
3高力丁,李兴.血半胱氨酸蛋白酶抑制剂C诊断肾功能损害的研究进展[J].医学综述,2004,10(11):693-695. 被引量:23
-
4曾娇娥,宁尚侠,王景丽.血清γ-痕迹蛋白对早期糖尿病肾病的诊断价值[J].华中医学杂志,2006,30(3):259-260. 被引量:1
-
5卢燕雯,朱秋毓,丁峰,顾勇,林善锬.次氯酸对人血清白蛋白的氧化修饰影响及与高级氧化蛋白产物的关系[J].中华肾脏病杂志,2006,22(8):488-493. 被引量:5
-
6吴光哲,张必利,郑兴,秦永文.慢性肾脏病与冠心病相关性的临床研究[J].心血管康复医学杂志,2006,15(5):447-450. 被引量:17
-
7王会玲(综述、审校),张金元(综述、审校).慢性肾衰竭患者营养不良-炎症复合体综合征的认识和研究[J].国际泌尿系统杂志,2007,27(4):555-559.
-
8赵瑛瑛,欧阳军,王建生,田晨光.半胱氨酸蛋白酶抑制剂C在糖尿病肾病中的诊断价值[J].中原医刊,2007,34(16):27-28. 被引量:2
-
9柳杨,何立波.派丽奥治疗干槽症的临床研究[J].浙江临床医学,2007,9(12):1674-1675.
-
10张玲.晚期慢性肾脏病动脉粥样硬化性心血管疾病发生发展的研究现状[J].内科理论与实践,2007,2(6):398-401. 被引量:2
-
1王晓,朱均权.血清半胱氨酸蛋白酶抑制剂C与尿β_2-微球蛋白检测对原发性高血压患者早期肾损害的临床意义[J].检验医学,2009,24(11):822-822. 被引量:3
-
2郭兑山,王富伟.血清前白蛋白的自动透射比浊法[J].中华医学检验杂志,1991,14(3):130-133. 被引量:2
-
3吴小文.妇科手术患者围术期的心理干预[J].中国当代医药,2010,17(30):115-116. 被引量:2
-
4李云.糖尿病肾病合并泌尿系感染的护理体会[J].齐鲁护理杂志,1997,3(2):27-28.
-
5麦美芳,周钰静.系统性红斑狼疮伴肾损害患者的护理[J].北方药学,2013,10(5):188-188.
-
6刘晓红,李云霞.脑出血合并肾功能损害患者的相关因素分析[J].山西医药杂志(上半月),2013,42(12):1389-1390. 被引量:1
-
7浦春,程前玉,浦金合,张熙勇.全自动生化分析仪透射比浊法测免疫复合物的分析[J].皖南医学院学报,1996,15(4):377-379. 被引量:2
-
8陶岚.老年高血压患者的社区护理[J].临床合理用药杂志,2010,3(18):141-141. 被引量:2
-
9于淼,罗萍,罗俊彪.个性化护理在老年高血压临床治疗中对患者并发症和血压的影响[J].中国医学创新,2017,14(6):88-91. 被引量:9
-
10成海恩,高嵩,吴先国,金亚平.血清视黄醇结合蛋白与尿素、肌酐及半胱氨酸蛋白酶抑制剂C的相关性探讨[J].检验医学,2010,25(7):567-568. 被引量:1